These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4790610)

  • 21. Inoculation experiments with Bordetella bronchiseptica strains in SPF pigs.
    Tornoe N; Nielsen NC
    Nord Vet Med; 1976; 28(4-5):233-42. PubMed ID: 934809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-conjugative R plasmid with five drug resistance from Bordetella bronchiseptica of pig origin.
    Terakado N; Araki S; Mori Y; Sekizaki T; Hashimoto K
    Nihon Juigaku Zasshi; 1981 Dec; 43(6):971-4. PubMed ID: 7343701
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of antibiotic resistance plasmids from Bordetella bronchiseptica.
    Speakman AJ; Binns SH; Osborn AM; Corkill JE; Kariuki S; Saunders JR; Dawson S; Gaskell RM; Hart CA
    J Antimicrob Chemother; 1997 Dec; 40(6):811-6. PubMed ID: 9462432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transferable antibiotic resistance in enteropathogenic Escherichia coli between 1948 and 1968.
    Slocombe B; Sutherland R
    Antimicrob Agents Chemother; 1973 Oct; 4(4):459-66. PubMed ID: 4598614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifactorial analysis of antibiotic sensitivity of Bordetella bronchiseptica isolates from guineapigs, rabbits and rats.
    Boot R; Thuis H; Wieten G
    Lab Anim; 1995 Jan; 29(1):45-9. PubMed ID: 7707677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bordetella bronchiseptica experimental model development in pigs and efficacy evaluation of a single intramuscular injection of gamithromycin (Zactran® for Swine) against Bordetella bronchiseptica-associated respiratory disease in experimentally infected piglets.
    Gupta A; Cortes-Dubly ML; Buellet P; Richard-Mazet A; Merdy O; Targa NL; Dumont P
    J Vet Pharmacol Ther; 2020 Mar; 43(2):197-207. PubMed ID: 31872885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of strains of Bordetella bronchiseptica resistant to potentiated sulphonamide in English pig herds in 1978-79.
    Smith IM; Oliphant J; Baskerville AJ; Giles CJ
    Vet Rec; 1980 May; 106(22):462-3. PubMed ID: 7001722
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug resistance and distribution of R factors in Salmonella strains.
    Tanaka T; Ikemura K; Tsunoda M; Sasagawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1976 Jan; 9(1):61-4. PubMed ID: 1259392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in antimicrobial susceptibility of Bordetella bronchiseptica caused by antigenic modulation and phase variation.
    Ishikawa H; Isayama Y; Ohmae K
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1891-2. PubMed ID: 3245700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of resistance to trimethoprim, chloramphenicol and sulphonamides in Bordetella bronchiseptica.
    Kadlec K; Kehrenberg C; Schwarz S
    J Antimicrob Chemother; 2005 Sep; 56(3):485-90. PubMed ID: 16046466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance and Hly plasmids in serotypes of Escherichia coli associated with porcine enteric disease.
    Jorgensen ST; Poulsen AL
    Antimicrob Agents Chemother; 1976 Jan; 9(1):6-10. PubMed ID: 769674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intranasal inoculation of porcine reproductive and respiratory syndrome virus, Bordetella bronchiseptica, or a combination of both organisms in pigs.
    Brockmeier SL; Palmer MV; Bolin SR
    Am J Vet Res; 2000 Aug; 61(8):892-9. PubMed ID: 10951978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transmission of drug-resistance through conjugation in Yersinia enterocolitica and Yersinia pseudotuberculosis. (II). With special reference to streptomycin resistant strains isolated from men and domestic animals (author's transl)].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1975 Aug; 28(4):538-41. PubMed ID: 1099269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of Bordetella avium plasmids.
    Jackwood MW; Saif YM; Coplin DL
    Avian Dis; 1987; 31(4):782-6. PubMed ID: 3442530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
    Rutter JM
    Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some characteristics of high macarbomycin-resistant mutants of Escherichia coli isolated from gnotobiotic pigs.
    Terakado N; Fukuyasu T; Shimizu T
    Natl Inst Anim Health Q (Tokyo); 1972; 12(4):207-12. PubMed ID: 4196209
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetical relationship between R plasmids derived from Salmonella and Escherichia coli obtained from a pig farm, and its epidemiological significance.
    Ishiguro N; Goto J; Sato G
    J Hyg (Lond); 1980 Jun; 84(3):365-79. PubMed ID: 6762390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interbacterial transfer of R factor in humans.
    Neu HC; Huber PJ; Winshell EB
    Antimicrob Agents Chemother; 1973 May; 3(5):542-4. PubMed ID: 4597729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis.
    Byrd DW; Roop RM; Veit HP; Schurig GG
    J Med Microbiol; 1991 Mar; 34(3):159-65. PubMed ID: 2010907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of Bordetella parapertussis to various antimicrobial agents.
    Watanabe M; Haraguchi Y
    Antimicrob Agents Chemother; 1989 Jun; 33(6):968-9. PubMed ID: 2764546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.